Genetic Screening and Gene Therapy: Proceed with Caution

"We now know that our fate is predominantly in our genes." James Watson, a co-founder of the famous double helix structure, said the famous vocabulary. With great influence, on the day of modern scientific belief, our destiny is controlled by our genes. Our genes control our physical statues, our appearance and basically our overall body composition is determined by our genes. Humans are approaching new areas of gene therapy and gene therapy and the way humans enter this field will greatly influence his morality, morality, and the universal acceptance of this newly discovered knowledge .

Gene therapy uses DNA as a drug for treating diseases. Gene therapy was originally conceptualized in 1972 and the authors urged attention before starting gene research on humans. The first FDA approved gene therapy trial in the US was held in 1990. This is a 4 year old girl named Ashanti DeSilva who received ADA - SCID treatment. This is a disease that prevents her from fighting infection. Dr. W French Anderson is the principal investigator of clinical trials and works at the National Heart, Lung and Blood Laboratory. Since then, more than 1,700 clinical trials have been performed using a variety of gene therapy technologies.

Gene therapy is still at development stage, genetically modified organisms in clinical trials have potential safety and infection problems. All human clinical trials conducted in Australia must be conducted under the clinical trial notification (CTN) or the clinical trial exemption program (CTX). In addition to observing CTN or CTX, any human clinical trial, including gene therapy, must be approved by the genetic technology regulatory body under the genetic technology law of 2000. The purpose of the genetic technology law is "to protect health and safety by identifying the risks caused by genetic or genetic technologies, protecting the environment, protecting the environment."

Genetic research Currently, researchers funded by the National Institutes of Health conduct various large-scale genetic studies. The rapid development of gene discovery technology will enable whole genome screening in TS and the discovery of TS gene or gene will be an important step in understanding genetic risk factors. In addition, understanding the genetics of TS genes can strengthen clinical diagnosis, improve genetic counseling, lead to elucidation of pathophysiology, and provide clues for more effective treatment.